US Patent Issued to PHC on Sept. 23 for "Use of sCD14 or its fragments or derivatives for risk stratification, diagnosis and prognosis" (German Inventor)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,422,439, issued on Sept. 23, was assigned to PHC Corp. (Ehime, Japan).

"Use of sCD14 or its fragments or derivatives for risk stratification, diagnosis and prognosis" was invented by Eberhard Spanuth (Dossenheim, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method for diagnosis of a cardiovascular disease or condition or atherosclerosis and for a method for evaluating the risk of a subject of developing the same. Methods are further provided for evaluating a subject's risk of mortality, for evaluating whether a subject will benefit from a certain treatment or whether a subject needs to be hospitalized or whe...